| Stage | ALRM | % of rev | PRLB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $278M | 100.00% | $154M | 100.00% | ALRM ×1.80 |
| Gross profit | $182M | 65.56% | $69M | 44.49% | ALRM +21.1pp |
| Operating income | $32M | 11.70% | $14M | 9.36% | ALRM +2.3pp |
| Pre-tax income | $31M | 11.20% | $16M | 10.50% | ALRM +0.7pp |
| Net income | $24M | 8.72% | $12M | 7.62% | ALRM +1.1pp |
| Stage | ALRM | PRLB | Gap · A − B |
|---|---|---|---|
| Revenue | $278M100.00% | $154M100.00% | ALRM ×1.80 |
| Gross profit | 65.56%$182M | 44.49%$69M | ALRM +21.1pp |
| Operating income | 11.70%$32M | 9.36%$14M | ALRM +2.3pp |
| Pre-tax income | 11.20%$31M | 10.50%$16M | ALRM +0.7pp |
| Net income |
| 8.72%$24M |
| 7.62%$12M |
| ALRM +1.1pp |
No disclosed counterparties: PRLB.
None